Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis
- 5 June 2018
- journal article
- research article
- Published by Wiley in The Clinical Respiratory Journal
- Vol. 12 (8) , 2378-2389
Abstract
Background: Acute exacerbation of idiopathic pulmonary fibrosis (AE‐IPF) has an extremely poor prognosis. The role of ferritin in the pathogenesis of AE‐IPF is not well known while serum ferritin is a key prognostic indicator for patients with clinically amyopathic dermatomyositis with rapidly progressive interstitial pneumonia.Objective: To elucidate the clinical importance of serum ferritin in patients with AE‐IPF.Methods: Thirty‐seven patients (48 episodes), who were diagnosed with AE‐IPF and treated at our hospital between 1997 and 2015, were retrospectively studied.Results: Patients with AE‐IPF had significantly higher levels of serum ferritin than baseline levels at the first diagnosis of IPF (P = 0.0017). Receiver operating characteristic analysis showed the cut‐off value 174 ng/mL for the separation of AE (area under the curve, 0.700). No patients with AE‐IPF were positive for anti‐ melanoma differentiation‐associated gene 5 antibody. Patients with AE‐IPF and higher ferritin (≥174 ng/mL) had lower %FVC and %DLCO before AE, and those with much higher ferritin (≥500 ng/mL) had significantly worse prognosis than those with lower ferritin (log‐rank, P = 0.024). Immunohistochemical staining in autopsy specimens showed alveolar macrophages that were producing ferritin. Finally, in multivariate Cox proportional hazards analyses, serum ferritin level of ≥500 ng/mL was a significant worse prognostic factor (hazard ratio 5.280, P = 0.046).Conclusion: Higher serum ferritin may be related to a worse prognosis in patients with AE‐IPF.Keywords
Funding Information
- Ministry of Health, Labour and Welfare
This publication has 28 references indexed in Scilit:
- Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group ReportAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Epidemiologic Survey of Japanese Patients with Idiopathic Pulmonary Fibrosis and Investigation of Ethnic DifferencesAmerican Journal of Respiratory and Critical Care Medicine, 2014
- The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndromeBMC Medicine, 2013
- The prognostic value of HRCT in myositis-associated interstitial lung diseaseRespiratory Medicine, 2013
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Polarization dictates iron handling by inflammatory and alternatively activated macrophagesHaematologica, 2010
- Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositisRheumatology, 2010
- Acute Exacerbations of Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Acute Exacerbation in Idiopathic Pulmonary FibrosisChest, 1993